(Q28337503)
Statements
Final report of the phase I trial of single-dose WR-2721 [S-2-(3-aminopropylamino)ethylphosphorothioic acid] (English)
0 references
December 1986
0 references
70
0 references
12
0 references
1389-93
0 references